Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss
GCE
1 other identifier
interventional
31
1 country
1
Brief Summary
The study will assess the effect of attending to stomach-cues of hunger and fullness on body weight and any additional benefit provided by open-label placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2019
CompletedFirst Posted
Study publicly available on registry
February 22, 2019
CompletedStudy Start
First participant enrolled
September 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2020
CompletedJune 4, 2021
June 1, 2021
8 months
February 20, 2019
June 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
BMI
Change in body mass index over 8 weeks on the protocol.
8 weeks
Study Arms (2)
Placebo group
EXPERIMENTALIn the first visit, this group will learn about placebo pills from a video and will be placebo pills to take twice a day for 8 weeks. They will be asked to take the pills in conjunction with following the weight-loss protocol.
No placebo group
EXPERIMENTALIn the first visit, this group will learn about placebo pills from a video but will not be given placebo pills. They will follow the weight-loss protocol without placebo pills.
Interventions
The placebo pills will be green and white gelatin capsules containing microcrystalline cellulose and other inert ingredients.
Eligibility Criteria
You may qualify if:
- Desire to lose weight
- years of age
- Student of employee at the University of Alabama at Birmingham
You may not qualify if:
- Current enrollment in commercial weight loss program
- Uncontrolled diabetes
- Uncontrolled hypertension
- Current bipolar disorder
- Current or history of eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
323 Campbell Hall
Birmingham, Alabama, 35249-1179, United States
Related Publications (1)
White TR, Wood AS, Ebeling M, Braswell AC, Lausen MA, Isaac S, Gampher JE, Boggiano MM. Change in craving and frequency of consuming palatable foods for non-homeostatic motives after a gut-cued eating intervention. Eat Behav. 2022 Aug;46:101656. doi: 10.1016/j.eatbeh.2022.101656. Epub 2022 Jul 28.
PMID: 35944376DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary M Boggiano, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 20, 2019
First Posted
February 22, 2019
Study Start
September 25, 2019
Primary Completion
May 30, 2020
Study Completion
May 30, 2020
Last Updated
June 4, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share